Case report: Bevacizumab-induced cerebrovascular events: a case series report and literature review
In clinical use, bevacizumab has improved the overall survival (OS) and progression-free survival (PFS) of malignant solid tumors, and the safe use of bevacizumab has gradually become the mainstream direction of clinical, nursing and pharmaceutical research. Bevacizumab is a humanized anti-VEGF drug...
Saved in:
Main Authors: | Ke Chen, Boyang Jiang, Huiping Yan, Liu Yang, Zheling Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1395129/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cerebrovascular ageing: how zebrafish can contribute to solving the puzzle
by: Guy Malkinson, et al.
Published: (2025-02-01) -
Modified autologous neurosensory retinal transplantation and bevacizumab injection in primary extra-large chronic macular holes
by: Hossein Ashraf, et al.
Published: (2025-06-01) -
Assessment of stress hyperglycemia ratio to predict all-cause mortality in patients with critical cerebrovascular disease: a retrospective cohort study from the MIMIC-IV database
by: Yuwen Chen, et al.
Published: (2025-02-01) -
Vascular Endothelial Growth Factor (VEGF) as a Biomarker for Cancer-Associated Venous Thrombosis: A Meta-analysis
by: Alison M. Brown, et al.
Published: (2025-01-01) -
Fundamentals of Graphic Art /
by: Apollo,Baker
Published: (2010)